In the Media Tag: Veru

FDA Gives COVID Drug with Memphis Ties Fast-Track to Emergency Use

In the Media Icon

Veru Inc., a company with deep ties to Memphis, has received the green light to seek permission from the FDA for fast-track emergency approval of a drug that more than cut in half deaths of people hospitalized for serious respiratory issues caused by COVID. To speed up the process, the FDA will not require Veru… Read More

Memphis scientists instrumental in new, landmark COVID drug

In the Media Icon

The next possible landmark COVID drug is so rich in Memphis DNA that if approved by the FDA, patent royalty checks will immediately flow to town, a legacy of the defunct GTx pharmaceutical company and scientists at the University of Tennessee Health Science Center who created the structure. Sabizabulin was originally created as an anti-cancer… Read More